Sartorius scoops double award at Fisher Scientific European Sales Conference
Company also promoted to Platinum supplier status in Europe.
Sartorius was a double award winner at the Fisher Scientific European Sales Conference in Malta, picking up the awards for Supplier Excellence and Best Booth. These awards coincided with the formal announcement of the promotion of Sartorius to Platinum supplier status in Europe.
The Supplier Excellence Award recognized the excellent cooperation between Fisher Scientific and Sartorius. The year 2017 saw the Sartorius business with Fisher Scientific increase. The award also recognizes Sartorius for supply chain excellence, product quality and marketing support. The Best Booth award, which is voted for by the Fisher Scientific Commercial team, is awarded to the supplier whose booth best incorporates the four values of Fisher Scientific: involvement, intensity, innovation and integrity.
John Collings, European Category Director at Fisher Scientific, announced the change in partnership and explained what it means for the relationship between the two companies. “This change is a significant long-term investment from both companies and will now help us move forward in strategic partnership. This promotion to Platinum will also drive ambitious revenue growth targets, through increased marketing, commercial, supply chain and strategic plans.”
Daniela Winzker-Demes, Sartorius’ Vice President of LPS Sales & Services EMEA, and John Bryson, Director Channel Management Europe, proudly accepted the awards. “The new status is an incentive for us to intensify our cooperation to continuously improve our customers’ experience," said Winzker-Demes. John Bryson commented: “These awards, and the move to Platinum status, reflect our shared success and close partnership with Fisher Scientific. We look forward to another successful year in 2018 as we work together to drive further growth and deliver solutions to our customers.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance